Volume 18, Issue 6 (June 2020)                   IJRM 2020, 18(6): 425-438 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Darbandi S, Darbandi M, Agarwal A, Khorram Khorshid H R, Sadeghi M R, C.Esteves S, et al . Comparing four laboratory three-parent techniques to construct human aged non-surrounded nucleolus germinal vesicle oocytes: A case-control study. IJRM 2020; 18 (6) :425-438
URL: http://ijrm.ir/article-1-1424-en.html
1- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
2- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. , mahsadarbandi@hotmail.com
3- American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio, 44195, USA.
4- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
5- Department of Embryology and Andrology, Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
6- Androfert, Andrology and Human Reproduction Clinic, Campinas, Brazil.
7- Department of Physiology, Faculty of Medicine, Mahsa University, Selangor, Malaysia.
8- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:   (2754 Views)
Background: The three-parent assisted reproductive technique may increase oocyte competence.
Objective: In this case-control study, the suitability of germinal vesicle transfer (GVT), synchronous ooplasmic transfer (sOT), asynchronous ooplasmic transfer using cryopreserved MII oocyte (caOT), and asynchronous ooplasmic transfer using waste MII oocyte (waOT) for maturation of the human-aged non-surrounded nucleolus germinal vesicle-stage (NSN-GV) oocyte were investigated.
Materials and Methods: NSN-GV oocytes were subjected to four methods: group A (GVT), B (sOT), C (caOT) D (waOT), and E (Control). The fusion rates, MI, MII, ICSI observations and cleavage at 2-cell, 4-cell, and 8-cell stages were compared in the groups.
Results: In GVT, none of the oocytes fused. In sOT, all oocytes fused, 20 achieved the MI, 14 progressed to MII, 8 fertilized, 6 cleaved and 5, 4, and 3 achieved the 2-cells, 4-cells and 8-cells, respectively. In caOT, all oocytes fused and achieved the MI, 8 progressed to MII and fertilized, 6 cleaved and 6, 5, and 5 achieved the 2-cells, 4-cells, and 8-cells respectively. In waOT, all oocytes fused, 5 and 3 progressed to MI and MII, respectively, but only one fertilized, cleaved and reached a 4-cells stage. In group E, 6 and 2 oocytes progressed to MI and MII, respectively, and only one fertilized but arrested at the zygote stage. caOT had the highest survival rate when compared to sOT (p = 0.04), waOT (p = 0.002), and control (p = 0.001).
Conclusion: The caOT method was beneficial over sOT, waOT, and GVT in supplementing the developmental capacity of human-aged NSN-GV oocytes.
Full-Text [PDF 22861 kb]   (798 Downloads) |   |   Full-Text (HTML)  (479 Views)  
Type of Study: Original Article | Subject: Reproductive Biology

References
1. Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online 2004; 8: 148-166. [DOI:10.1016/S1472-6483(10)60511-1]
2. Gonzalez-Ortega C, Pina-Aguilar RE, Cancino-Villarreal P, Perez-Pena E, Gutierrez-Gutierrez AM. Natural-cycle in vitro fertilization (IVF) combined with in vitro maturation in infertile patients with polycystic ovarian syndrome (PCOS) requiring IVF. Taiwan J Obstet Gynecol 2019; 58: 192-195. [DOI:10.1016/j.tjog.2019.01.004] [PMID]
3. Albertini DF. In vivo veritas, in vitro-not so sure when it comes to ARTs. J Assist Reprod Genet 2019; 36: 361-362. [DOI:10.1007/s10815-019-01435-8] [PMID] [PMCID]
4. Darbandi S, Darbandi M, Khorram Khorshid HR, Sadeghi MR, Agarwal A, Sengupta P, et al. Ooplasmic transfer in human oocytes: efficacy and concerns in assisted reproduction. Reprod Biol Endocrinol 2017; 15: 77-87. [DOI:10.1186/s12958-017-0292-z] [PMID] [PMCID]
5. Monti M, Calligaro A, Behr B, Rejo Pera R, Redi CA, Wossidlo M. Functional topography of the fully grown human oocyte. Eur J Histochem 2017; 61: 2769. [DOI:10.4081/ejh.2017.2769] [PMID] [PMCID]
6. Fulka H, Kyogoku H, Zatsepina O, Langerova A Fulka J Jr. Can nucleoli be markers of developmental potential in human zygotes? Trends Mol Med 2015; 21: 663-672. [DOI:10.1016/j.molmed.2015.09.005] [PMID]
7. Monti M, Redi CA. Isolation and characterization of mouse antral oocytes based on nucleolar chromatin organization. J Vis Exp 2016; 11: 1-7. [DOI:10.3791/53616] [PMID] [PMCID]
8. Strowitzki T. In vitro maturation (IVM) of human oocytes. Arch Gynecol Obstet 2013; 288: 971-975. [DOI:10.1007/s00404-013-3033-3] [PMID]
9. Monti M, Zanoni M, Calligaro A, Ko MS, Mauri P Redi CA. Developmental arrest and mouse antral not-surrounded nucleolus oocytes. Biol Reprod 2013; 88: 1-7. [DOI:10.1095/biolreprod.112.103887] [PMID] [PMCID]
10. Liu K, Case A, Reproductive Endocrinology and Infertility Committee. Advanced reproductive age and fertility. J Obstet Gynaecol Can 2011; 33: 1165-1175. [DOI:10.1016/S1701-2163(16)35087-3]
11. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 2007; 18: 58-65. [DOI:10.1016/j.tem.2007.01.004] [PMID]
12. Darbandi S, Darbandi M, Khorshid HR, Sadeghi MR, Al-Hasani S, Agarwal A, et al. Experimental strategies towards increasing intracellular mitochondrial activity in oocytes: A systematic review. Mitochondrion 2016; 30: 8-17. [DOI:10.1016/j.mito.2016.05.006] [PMID]
13. Ghumman S. Principles and practice of controlled ovarian stimulation in ART. Berlin, Germany Springer; 2015. [DOI:10.1007/978-81-322-1686-5]
14. Aboulghar M, Rizk B. Ovarian stimulation. United Kingdom Cambridge University Press; 2010. [DOI:10.1017/CBO9780511762390]
15. Wang CT, Liang L, Witz C, Williams D, Griffith J, Skorupski J, et al. Optimized protocol for cryopreservation of human eggs improves developmental competence and implantation of resulting embryos. J Ovarian Res 2013; 6: 15. [DOI:10.1186/1757-2215-6-15] [PMID] [PMCID]
16. Darbandi S, Darbandi M, Khorram Khorshid HR, Shirazi A, Sadeghi MR, Agarwal A, et al. Reconstruction of mammalian oocytes by germinal vesicle transfer: A systematic review. Int J Reprod Biomed 2017; 15: 601-612. https://doi.org/10.29252/ijrm.15.10.2 [DOI:10.29252/ijrm.15.10.1]
17. Han Z, Cheng Y, Liang CG, Latham KE. Nuclear transfer in mouse oocytes and embryos. Methods Enzymol 2010; 476: 171-184. [DOI:10.1016/S0076-6879(10)76010-9]
18. Fulka H. Distribution of mitochondria in reconstructed mouse oocytes. Reproduction 2004; 127: 195-200. [DOI:10.1530/rep.1.00093] [PMID]
19. Sayaka W, Satoshi K, Van Thuan N, Hiroshi O, Takafusa H, Eiji M, et al. Effect of volume of oocyte cytoplasm on embryo development after parthenogenetic activation, intracytoplasmic sperm injection, or somatic cell nuclear transfer. Zygote 2008; 16: 211-222. [DOI:10.1017/S0967199408004620] [PMID]
20. WHO. WHO laboratory manual for the examination and processing of human semen. SwitzerlandWorld Health Organization; 2010.
21. Miyara F, Migne C, Dumont‐Hassan M, Le Meur A, Cohen‐Bacrie P, Aubriot FX, et al. Chromatin configuration and transcriptional control in human and mouse oocytes. Mol Reprod Dev 2003; 64: 458-470. [DOI:10.1002/mrd.10233] [PMID]
22. Liu H, Chang HC, Zhang J, Grifo J, Krey LC. Metaphase II nuclei generated by germinal vesicle transfer in mouse oocytes support embryonic development to term. Hum Reprod 2003; 18: 1903-1907. [DOI:10.1093/humrep/deg372] [PMID]
23. Patrizio P, Fragouli E, Bianchi V, Borini A, Wells D. Molecular methods for selection of the ideal oocyte. Reprod Biomed Online 2007; 15: 346-353. [DOI:10.1016/S1472-6483(10)60349-5]
24. Rienzi L, Ubaldi F, Martinez F, Iacobelli M, Minasi MG, Ferrero S, et al. Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI. Hum Reprod 2003; 18: 1289-1293. [DOI:10.1093/humrep/deg274] [PMID]
25. Chiaratti MR, Meirelles FV, Wells D, Poulton J. Therapeutic treatments of mtDNA diseases at the earliest stages of human development. Mitochondrion 2011; 11: 820-828. [DOI:10.1016/j.mito.2010.11.004] [PMID]
26. Ferreira CR, Burgstaller JP, Perecin F, Garcia JM, Chiaratti MR, Meo SC, et al. Pronounced segregation of donor mitochondria introduced by bovine ooplasmic transfer to the female germ-line. Biol Reprod 2010; 82: 563-571. [DOI:10.1095/biolreprod.109.080564] [PMID]
27. Wolf DP, Mitalipov N, Mitalipov S. Mitochondrial replacement therapy in reproductive medicine. Trends Mol Med 2015; 21: 68-76. [DOI:10.1016/j.molmed.2014.12.001] [PMID] [PMCID]
28. Darbandi M, Darbandi S. Three-Parent IVF Methods in Aged Oocytes and Oocytes with Mitochondrial Problems. Cresco J Reprod Sci 2016; 1: 1-2.

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb